Related Experiment Video

Updated: Jul 7, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

[Cardiovascular prevention in the over-80 age group is not beneficial]

W de Ruijter1, J Gussekloo

  • 1Leids Universitair Medisch Centrum, afd. Public Health en Eerstelijnsgeneeskunde, Postbus 9600, 2300 RC Leiden. w.de_ruijter@lumc.nl

Nederlands Tijdschrift Voor Geneeskunde
|February 5, 2008
PubMed

Insights

Preventing cardiovascular disease in the oldest old is crucial due to high rates. However, evidence for effective interventions and identifying at-risk elderly individuals is currently lacking.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) poses a significant health burden on the oldest old population, necessitating preventive strategies.
  • Current evidence supporting the efficacy of primary and secondary CVD prevention interventions in this demographic is scarce.
  • Identifying elderly individuals at high risk for developing new cardiovascular events remains a challenge.

Discussion:

  • The lack of evidence hinders the implementation of targeted CVD prevention programs for the oldest old.
  • Further research is required to establish effective preventive measures tailored to the unique needs of this age group.
  • Risk stratification models for CVD in the oldest old need development and validation.

Key Insights:

  • High prevalence and incidence of cardiovascular disease in the oldest old warrant preventive measures.
  • There is a significant gap in evidence regarding the effectiveness of preventive interventions for this population.
  • Identifying individuals at risk for primary CVD prevention in the elderly is an unmet need.

Outlook:

  • Future research should focus on evaluating the effectiveness of various CVD prevention strategies in the oldest old.
  • Developing reliable methods to identify at-risk elderly individuals is essential for effective primary prevention.
  • Translating research findings into clinical practice will improve cardiovascular health outcomes in aging populations.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...